BBIO vs. ^GSPC
Compare and contrast key facts about BridgeBio Pharma, Inc. (BBIO) and S&P 500 (^GSPC).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BBIO or ^GSPC.
Correlation
The correlation between BBIO and ^GSPC is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
BBIO vs. ^GSPC - Performance Comparison
Key characteristics
BBIO:
-0.55
^GSPC:
2.16
BBIO:
-0.54
^GSPC:
2.87
BBIO:
0.94
^GSPC:
1.40
BBIO:
-0.44
^GSPC:
3.19
BBIO:
-0.84
^GSPC:
13.87
BBIO:
36.41%
^GSPC:
1.95%
BBIO:
55.59%
^GSPC:
12.54%
BBIO:
-92.80%
^GSPC:
-56.78%
BBIO:
-60.57%
^GSPC:
-0.82%
Returns By Period
In the year-to-date period, BBIO achieves a -29.33% return, which is significantly lower than ^GSPC's 26.63% return.
BBIO
-29.33%
21.82%
22.03%
-30.52%
-7.90%
N/A
^GSPC
26.63%
1.18%
10.44%
27.03%
13.30%
11.23%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BBIO vs. ^GSPC - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for BridgeBio Pharma, Inc. (BBIO) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Drawdowns
BBIO vs. ^GSPC - Drawdown Comparison
The maximum BBIO drawdown since its inception was -92.80%, which is greater than ^GSPC's maximum drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for BBIO and ^GSPC. For additional features, visit the drawdowns tool.
Volatility
BBIO vs. ^GSPC - Volatility Comparison
BridgeBio Pharma, Inc. (BBIO) has a higher volatility of 20.69% compared to S&P 500 (^GSPC) at 3.96%. This indicates that BBIO's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.